Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Edvinsson, L; Sams, A; Jansen-Olesen, I; Tajti, J; Kane, SA; Rutledge, RZ; Koblan, KS; Hill, RG; Longmore, J
   Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries
   EUROPEAN JOURNAL OF PHARMACOLOGY
   
   L. Edvinsson et al., "Characterisation of the effects of a non-peptide CGRP receptor antagonist in SK-N-MC cells and isolated human cerebral arteries", EUR J PHARM, 415(1), 2001, pp. 39-44
2. Hasbak, P; Sams, A; Schifter, S; Longmore, J; Edvinsson, L
   CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (W098/11128), a non-peptide antagonist
   BRITISH JOURNAL OF PHARMACOLOGY
   
   P. Hasbak et al., "CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (W098/11128), a non-peptide antagonist", BR J PHARM, 133(8), 2001, pp. 1405-1413
3. Hou, MY; Kanje, M; Longmore, J; Tajti, J; Uddman, R; Edvinsson, L
   5-HT1B and 5-HT1D receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase
   BRAIN RESEARCH
   
   M.Y. Hou et al., "5-HT1B and 5-HT1D receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase", BRAIN RES, 909(1-2), 2001, pp. 112-120
4. Uddman, R; Longmore, J; Cardell, LO; Edvinsson, L
   Expression of 5-HT1B receptors in human nasal mucosa
   ACTA OTO-LARYNGOLOGICA
   
   R. Uddman et al., "Expression of 5-HT1B receptors in human nasal mucosa", ACT OTO-LAR, 121(3), 2001, pp. 403-406
5. Hargreaves, RJ; Longmore, J; Beer, M; Shepheard, S; Cumberbatch, M; Williamson, D; Stanton, J; Razzaque, Z; Sohal, B; Street, L; Seabrook, G; Hill, R
   The pharmacology and mechanisms of action of rizatriptan
   DRUG TREATMENT OF MIGRAINE AND OTHER HEADACHES
   
   R.J. Hargreaves et al., "The pharmacology and mechanisms of action of rizatriptan", MG CLIN NEU, 17, 2000, pp. 141-161
6. Bock, MG; Longmore, J
   Bradykinin antagonists: new opportunities
   CURRENT OPINION IN CHEMICAL BIOLOGY
   
   M.G. Bock e J. Longmore, "Bradykinin antagonists: new opportunities", CURR OP C B, 4(4), 2000, pp. 401-406
7. Longmore, J; Maguire, JJ; MacLeod, A; Street, L; Schofield, WN; Hill, RG
   Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptoragonist L-775,606 with the mixed 5-HT1B/(1D)-receptor agonist sumatriptan and 5-HT in human isolated coronary artery
   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
   
   J. Longmore et al., "Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptoragonist L-775,606 with the mixed 5-HT1B/(1D)-receptor agonist sumatriptan and 5-HT in human isolated coronary artery", BR J CL PH, 49(2), 2000, pp. 126-131
8. Olivar, T; Razzaque, Z; Nwagwu, M; Longmore, J
   Neurogenic vasodilation in rabbit basilar isolated artery: involvement of calcitonin-gene related peptide
   EUROPEAN JOURNAL OF PHARMACOLOGY
   
   T. Olivar et al., "Neurogenic vasodilation in rabbit basilar isolated artery: involvement of calcitonin-gene related peptide", EUR J PHARM, 395(1), 2000, pp. 61-68
9. Razzaque, Z; Heald, MA; Pickard, JD; Maskell, L; Beer, MS; Hill, RG; Longmore, J
   Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation
   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
   
   Z. Razzaque et al., "Vasoconstriction in human isolated middle meningeal arteries: determining the contribution of 5-HT1B- and 5-HT1F-receptor activation", BR J CL PH, 47(1), 1999, pp. 75-82
10. Nilsson, T; Longmore, J; Shaw, D; Pantev, E; Bard, JA; Branchek, T; Edvinsson, L
    Characterisation of 5-HT receptors in human coronary arteries by molecularand pharmacological techniques
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    T. Nilsson et al., "Characterisation of 5-HT receptors in human coronary arteries by molecularand pharmacological techniques", EUR J PHARM, 372(1), 1999, pp. 49-56
11. Nilsson, T; Longmore, J; Shaw, D; Olesen, IJ; Edvinsson, L
    Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry
    BRITISH JOURNAL OF PHARMACOLOGY
    
    T. Nilsson et al., "Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry", BR J PHARM, 128(6), 1999, pp. 1133-1140
12. Bonafini, L; Thomas, SR; Hill, RG; Longmore, J
    beta-amyloid inhibits endothelial-dependent relaxations in rabbit isolatedaorta: An interaction between superoxide radicals and nitric oxide?
    ALZHEIMERS REPORTS
    
    L. Bonafini et al., "beta-amyloid inhibits endothelial-dependent relaxations in rabbit isolatedaorta: An interaction between superoxide radicals and nitric oxide?", ALZHEIM REP, 1(5), 1998, pp. 297-302
13. Longmore, J; Razzaque, Z; Shaw, D; Davenport, AP; Maguire, J; Pickard, JD; Schofield, WN; Hill, RG
    Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    
    J. Longmore et al., "Comparison of the vasoconstrictor effects of rizatriptan and sumatriptan in human isolated cranial arteries: immunohistological demonstration of the involvement of 5-HT1B-receptors", BR J CL PH, 46(6), 1998, pp. 577-582
14. ANDERSEN MT; LONGMORE J; LIEFTING LW; WOOD GA; SUTHERLAND PW; BECK DL; FORSTER RLS
    PHORMIUM YELLOW LEAF PHYTOPLASMA IS ASSOCIATED WITH STRAWBERRY LETHALYELLOWS DISEASE IN NEW-ZEALAND
    Plant disease
    
    M.T. Andersen et al., "PHORMIUM YELLOW LEAF PHYTOPLASMA IS ASSOCIATED WITH STRAWBERRY LETHALYELLOWS DISEASE IN NEW-ZEALAND", Plant disease, 82(6), 1998, pp. 606-609
15. SMITH D; SHAW D; HOPKINS R; MCALLISTER G; HILL R; SIRINATHSINGHJI D; LONGMORE J
    DEVELOPMENT AND CHARACTERIZATION OF HUMAN 5-HT1B-RECEPTOR OR 5-HT1D-RECEPTOR SPECIFIC ANTIBODIES AS UNIQUE RESEARCH TOOLS
    Journal of neuroscience methods
    
    D. Smith et al., "DEVELOPMENT AND CHARACTERIZATION OF HUMAN 5-HT1B-RECEPTOR OR 5-HT1D-RECEPTOR SPECIFIC ANTIBODIES AS UNIQUE RESEARCH TOOLS", Journal of neuroscience methods, 80(2), 1998, pp. 155-161
16. LONGMORE J; SHAW D; SMITH D; HOPKINS R; MCALLISTER G; PICKARD JD; SIRINATHSINGHJI DJS; BUTLER AJ; HILL RG
    DIFFERENTIAL DISTRIBUTION OF 5HT(1D)-IMMUNOREACTIVITY AND 5HT(1B)-IMMUNOREACTIVITY WITHIN THE HUMAN TRIGEMINO-CEREBROVASCULAR SYSTEM - IMPLICATIONS FOR THE DISCOVERY OF NEW ANTIMIGRAINE DRUGS
    Cephalalgia
    
    J. Longmore et al., "DIFFERENTIAL DISTRIBUTION OF 5HT(1D)-IMMUNOREACTIVITY AND 5HT(1B)-IMMUNOREACTIVITY WITHIN THE HUMAN TRIGEMINO-CEREBROVASCULAR SYSTEM - IMPLICATIONS FOR THE DISCOVERY OF NEW ANTIMIGRAINE DRUGS", Cephalalgia, 17(8), 1997, pp. 833-842
17. SANTAGATI A; LONGMORE J; GUCCIONE S; LANGER T; TONNEL E; MODICA M; SANTAGATI M; SCOLARO LM; RUSSO F
    BUILDING A MODEL OF INTERACTION AT THE NK-2 RECEPTORS - POLYCONDENSEDHETEROCYCLES CONTAINING THE PYRIMIDOINDOLE SKELETONS
    European journal of medicinal chemistry
    
    A. Santagati et al., "BUILDING A MODEL OF INTERACTION AT THE NK-2 RECEPTORS - POLYCONDENSEDHETEROCYCLES CONTAINING THE PYRIMIDOINDOLE SKELETONS", European journal of medicinal chemistry, 32(12), 1997, pp. 973-985
18. LONGMORE J; RAZZAQUE Z; SCHOFIELD WN; TAYLOR AA; BROWN MJ; PICKARD J; HILL RG; HARGREAVES RJ
    RIZATRIPTAN SHOWS CRANIOVASCULAR SELECTIVITY FOR HUMAN ISOLATED MIDDLE MENINGEAL OVER CORONARY-ARTERIES - A COMPARISON WITH SUMATRIPTAN
    Neurology
    
    J. Longmore et al., "RIZATRIPTAN SHOWS CRANIOVASCULAR SELECTIVITY FOR HUMAN ISOLATED MIDDLE MENINGEAL OVER CORONARY-ARTERIES - A COMPARISON WITH SUMATRIPTAN", Neurology, 48(3), 1997, pp. 1133-1133
19. LONGMORE J; HILL RG; HARGREAVES RJ
    NEUROKININ-RECEPTOR ANTAGONISTS - PHARMACOLOGICAL TOOLS AND THERAPEUTIC DRUGS
    Canadian journal of physiology and pharmacology
    
    J. Longmore et al., "NEUROKININ-RECEPTOR ANTAGONISTS - PHARMACOLOGICAL TOOLS AND THERAPEUTIC DRUGS", Canadian journal of physiology and pharmacology, 75(6), 1997, pp. 612-621
20. RAZZAQUE Z; SHAW D; SMITH D; HOPKINS R; SIRINATHSINGHJI D; MASKELL L; STANTON JA; BEER MS; HILL RG; PICKARD J; LONGMORE J
    PHARMACOLOGICAL ANALYSIS OF 5-HT-RECEPTOR-MEDIATED VASOCONSTRICTION OF HUMAN MIDDLE MENINGEAL ARTERIES - DETERMINING THE CONTRIBUTION OF 5-HT1B AND 5-HT1F RECEPTOR ACTIVATION
    British Journal of Pharmacology
    
    Z. Razzaque et al., "PHARMACOLOGICAL ANALYSIS OF 5-HT-RECEPTOR-MEDIATED VASOCONSTRICTION OF HUMAN MIDDLE MENINGEAL ARTERIES - DETERMINING THE CONTRIBUTION OF 5-HT1B AND 5-HT1F RECEPTOR ACTIVATION", British Journal of Pharmacology, 120, 1997, pp. 211-211
21. STERNFELD F; BAKER R; BROUGHTON HB; GUIBLIN AR; JELLEY RA; MATASSA VG; REEVE AJ; BEER MS; STANTON JA; HARGREAVES RJ; SHEPHEARD SL; LONGMORE J; RAZZAQUE Z; GRAHAM MI; SOHAL B; STREET LJ
    THE CHEMICAL EVOLUTION OF 2-[5-(1,2,4-TRIAZOL-4-YL)-1H-INDOL-3-YL]ETHYLAMINE (L-741,604) AND ANALOGS - POTENT AND SELECTIVE AGONISTS FOR 5-HT1D RECEPTORS
    Bioorganic & medicinal chemistry letters
    
    F. Sternfeld et al., "THE CHEMICAL EVOLUTION OF 2-[5-(1,2,4-TRIAZOL-4-YL)-1H-INDOL-3-YL]ETHYLAMINE (L-741,604) AND ANALOGS - POTENT AND SELECTIVE AGONISTS FOR 5-HT1D RECEPTORS", Bioorganic & medicinal chemistry letters, 6(15), 1996, pp. 1825-1830
22. GUCCIONE S; MODICA M; LONGMORE J; SHAW D; BARRETTA GU; SANTAGATI A; SANTAGATI M; RUSSO F
    SYNTHESIS AND NK-2 ANTAGONIST EFFECT OF -PYRAZOLO[3,4-D]-THIAZOLO[3,2-A]4H-PYRIMIDIN-4-ONE
    Bioorganic & medicinal chemistry letters
    
    S. Guccione et al., "SYNTHESIS AND NK-2 ANTAGONIST EFFECT OF -PYRAZOLO[3,4-D]-THIAZOLO[3,2-A]4H-PYRIMIDIN-4-ONE", Bioorganic & medicinal chemistry letters, 6(1), 1996, pp. 59-64
23. LONGMORE J; BOULANGER CM; DESTA B; HILL RG; SCHOFIELD WN; TAYLOR AA
    5-HT1D RECEPTOR AGONISTS AND HUMAN CORONARY-ARTERY REACTIVITY IN-VITRO - CROSSOVER COMPARISONS OF 5-HT AND SUMATRIPTAN WITH RIZATRIPTAN ANDL-741,519
    British journal of clinical pharmacology
    
    J. Longmore et al., "5-HT1D RECEPTOR AGONISTS AND HUMAN CORONARY-ARTERY REACTIVITY IN-VITRO - CROSSOVER COMPARISONS OF 5-HT AND SUMATRIPTAN WITH RIZATRIPTAN ANDL-741,519", British journal of clinical pharmacology, 42(4), 1996, pp. 431-441
24. SHAW D; STANTON JA; HEALD MA; BEER MS; STERNFELD F; STREET L; HILL RG; COOKE E; LONGMORE J
    IN-VITRO ASSESSMENT OF THE VASCULAR EFFECTS OF 5-HT1D-RECEPTOR AGONISTS - RELATIONSHIPS WITH 5-HT1D-ALPHA-RECEPTOR OR 5-HT1D-BETA-RECEPTOR BINDING-AFFINITY
    British Journal of Pharmacology
    
    D. Shaw et al., "IN-VITRO ASSESSMENT OF THE VASCULAR EFFECTS OF 5-HT1D-RECEPTOR AGONISTS - RELATIONSHIPS WITH 5-HT1D-ALPHA-RECEPTOR OR 5-HT1D-BETA-RECEPTOR BINDING-AFFINITY", British Journal of Pharmacology, 119, 1996, pp. 112-112
25. RAZZAQUE Z; BAKER R; BEER MS; HILL RG; MATASSA VG; STAGG AT; STERNFELD F; STREET L; LONGMORE J
    IN-VITRO PHARMACOLOGICAL EFFECTS OF 2 NOVEL 5-HT1D-RECEPTOR AGONISTS L-741,519 AND L-741,604 - COMPARISON WITH SUMATRIPTAN AND BW311C
    British Journal of Pharmacology
    
    Z. Razzaque et al., "IN-VITRO PHARMACOLOGICAL EFFECTS OF 2 NOVEL 5-HT1D-RECEPTOR AGONISTS L-741,519 AND L-741,604 - COMPARISON WITH SUMATRIPTAN AND BW311C", British Journal of Pharmacology, 117, 1996, pp. 119-119
26. ASONGANYI B; BORKOWSKI J; HESS JF; SHAW D; HILL RG; LONGMORE J
    INDUCTION OF B-1-RECEPTOR-MEDIATED FUNCTIONAL-RESPONSES IN MOUSE URINARY-BLADDER - EFFECTS OF GENETIC DEPLETION OF THE B-2-RECEPTOR GENE
    British Journal of Pharmacology
    
    B. Asonganyi et al., "INDUCTION OF B-1-RECEPTOR-MEDIATED FUNCTIONAL-RESPONSES IN MOUSE URINARY-BLADDER - EFFECTS OF GENETIC DEPLETION OF THE B-2-RECEPTOR GENE", British Journal of Pharmacology, 117, 1996, pp. 196-196
27. FERRO A; LONGMORE J; HILL RG; BROWN MJ
    A COMPARISON OF THE CONTRACTILE EFFECTS OF 5-HYDROXYTRYPTAMINE, SUMATRIPTAN AND MK-462 ON HUMAN CORONARY-ARTERY IN-VITRO
    British journal of clinical pharmacology
    
    A. Ferro et al., "A COMPARISON OF THE CONTRACTILE EFFECTS OF 5-HYDROXYTRYPTAMINE, SUMATRIPTAN AND MK-462 ON HUMAN CORONARY-ARTERY IN-VITRO", British journal of clinical pharmacology, 40(3), 1995, pp. 245-251
28. HUTSON PH; BRISTOW LJ; CUNNINGHAM JR; HOGG JE; LONGMORE J; MURRAY F; PEARCE D; RAZZAQUE Z; SAYWELL K; TRICKLEBANK MD; YOUNG L
    THE EFFECTS OF GR127935, A PUTATIVE 5-HT1D RECEPTOR ANTAGONIST, ON BRAIN 5-HT METABOLISM, EXTRACELLULAR 5-HT CONCENTRATION AND BEHAVIOR IN THE GUINEA-PIG
    Neuropharmacology
    
    P.H. Hutson et al., "THE EFFECTS OF GR127935, A PUTATIVE 5-HT1D RECEPTOR ANTAGONIST, ON BRAIN 5-HT METABOLISM, EXTRACELLULAR 5-HT CONCENTRATION AND BEHAVIOR IN THE GUINEA-PIG", Neuropharmacology, 34(4), 1995, pp. 383-392
29. RAZZAQUE Z; LONGMORE J; HILL RG
    DIFFERENCES IN THE EFFECTS OF KETANSERIN AND GR127935 ON 5-HT-RECEPTOR MEDIATED RESPONSES IN RABBIT SAPHENOUS-VEIN AND GUINEA-PIG JUGULAR-VEIN
    European journal of pharmacology
    
    Z. Razzaque et al., "DIFFERENCES IN THE EFFECTS OF KETANSERIN AND GR127935 ON 5-HT-RECEPTOR MEDIATED RESPONSES IN RABBIT SAPHENOUS-VEIN AND GUINEA-PIG JUGULAR-VEIN", European journal of pharmacology, 283(1-3), 1995, pp. 199-206
30. BOULANGER CM; LONGMORE J; DESTA B; SCHOFIELD W; HILL RG; TAYLOR AA
    FURTHER-STUDIES ON THE RESPONSE OF HUMAN CORONARY-ARTERIES TO THE 5-HT1D RECEPTOR AGONISTS SUMATRIPTAN AND MK-462
    British Journal of Pharmacology
    
    C.M. Boulanger et al., "FURTHER-STUDIES ON THE RESPONSE OF HUMAN CORONARY-ARTERIES TO THE 5-HT1D RECEPTOR AGONISTS SUMATRIPTAN AND MK-462", British Journal of Pharmacology, 116, 1995, pp. 38-38
31. FERRO A; LONGMORE J; HILL RG; BROWN MJ
    A COMPARISON OF THE CONTRACTILE EFFECTS OF 5-HT, SUMATRIPTAN AND MK-462 ON HUMAN CORONARY-ARTERY IN-VITRO
    British Journal of Pharmacology
    
    A. Ferro et al., "A COMPARISON OF THE CONTRACTILE EFFECTS OF 5-HT, SUMATRIPTAN AND MK-462 ON HUMAN CORONARY-ARTERY IN-VITRO", British Journal of Pharmacology, 114, 1995, pp. 162-162
32. LONGMORE J; HOGG JE; HUTSON PH; HILL RG
    EFFECTS OF 2 TRUNCATED FORMS OF HUMAN CALCITONIN-GENE-RELATED PEPTIDE- IMPLICATIONS FOR RECEPTOR CLASSIFICATION
    European journal of pharmacology
    
    J. Longmore et al., "EFFECTS OF 2 TRUNCATED FORMS OF HUMAN CALCITONIN-GENE-RELATED PEPTIDE- IMPLICATIONS FOR RECEPTOR CLASSIFICATION", European journal of pharmacology, 265(1-2), 1994, pp. 53-59
33. LONGMORE J; RAZZAQUE Z; SHAW D; HILL RG
    DIFFERENCES IN THE EFFECTS OF NK1-RECEPTOR ANTAGONISTS, (PLUS-OR-MINUS)-CP-96,345 AND CP-99,994, ON AGONIST-INDUCED RESPONSES IN GUINEA-PIGTRACHEA
    British Journal of Pharmacology
    
    J. Longmore et al., "DIFFERENCES IN THE EFFECTS OF NK1-RECEPTOR ANTAGONISTS, (PLUS-OR-MINUS)-CP-96,345 AND CP-99,994, ON AGONIST-INDUCED RESPONSES IN GUINEA-PIGTRACHEA", British Journal of Pharmacology, 112(1), 1994, pp. 176-178
34. RAZZAQUE Z; LONGMORE J; HILL RG
    DIFFERENCES IN THE EFFECTS OF KETANSERIN ON 5-HT-RECEPTOR-MEDIATED RESPONSES IN RABBIT SAPHENOUS-VEIN AND GUINEA-PIG JUGULAR-VEIN
    British Journal of Pharmacology
    
    Z. Razzaque et al., "DIFFERENCES IN THE EFFECTS OF KETANSERIN ON 5-HT-RECEPTOR-MEDIATED RESPONSES IN RABBIT SAPHENOUS-VEIN AND GUINEA-PIG JUGULAR-VEIN", British Journal of Pharmacology, 112, 1994, pp. 210000025-210000025
35. LONGMORE J; FONG TM; HILL RG
    THE SUSCEPTIBILITY OF AGONIST-EVOKED RESPONSES TO ANTAGONISM BY (+ -)CP96345 AND RP67580 DIFFERS FOR HUMAN AND RAT CLONED NK1 RECEPTORS/
    British Journal of Pharmacology
    
    J. Longmore et al., "THE SUSCEPTIBILITY OF AGONIST-EVOKED RESPONSES TO ANTAGONISM BY (+ -)CP96345 AND RP67580 DIFFERS FOR HUMAN AND RAT CLONED NK1 RECEPTORS/", British Journal of Pharmacology, 112, 1994, pp. 210000045-210000045
36. TAN KKC; BROWN MJ; LONGMORE J; PLUMPTON C; HILL RG
    DEMONSTRATION OF THE NEUROTRANSMITTER ROLE OF CALCITONIN-GENE-RELATEDPEPTIDES (CGRP) BY IMMUNOBLOCKADE WITH ANTI-CGRP MONOCLONAL-ANTIBODIES
    British Journal of Pharmacology
    
    K.K.C. Tan et al., "DEMONSTRATION OF THE NEUROTRANSMITTER ROLE OF CALCITONIN-GENE-RELATEDPEPTIDES (CGRP) BY IMMUNOBLOCKADE WITH ANTI-CGRP MONOCLONAL-ANTIBODIES", British Journal of Pharmacology, 111(3), 1994, pp. 703-710
37. TOTA MR; DANIEL S; SIROTINA A; MAZINA KE; FONG TM; LONGMORE J; STRADER CD
    CHARACTERIZATION OF A FLUORESCENT SUBSTANCE-P ANALOG
    Biochemistry
    
    M.R. Tota et al., "CHARACTERIZATION OF A FLUORESCENT SUBSTANCE-P ANALOG", Biochemistry, 33(44), 1994, pp. 13079-13086
38. RAZZAQUE Z; LONGMORE J
    COMPARISON OF THE EFFECTS OF (+ -) CP 96,345 AND L-668,169 ON NEUROKININ RECEPTOR-MEDIATED RESPONSES IN RAT AND GUINEA-PIG ISOLATED-TISSUES/
    Neuropeptides
    
    Z. Razzaque e J. Longmore, "COMPARISON OF THE EFFECTS OF (+ -) CP 96,345 AND L-668,169 ON NEUROKININ RECEPTOR-MEDIATED RESPONSES IN RAT AND GUINEA-PIG ISOLATED-TISSUES/", Neuropeptides, 25(3), 1993, pp. 169-174
39. SEABROOK GR; MAIN MJ; RAZZAQUE Z; LONGMORE J
    DIFFERENCES IN THE EFFECTS OF TACHYKININ NK(1) RECEPTOR ANTAGONISTS -NEURONAL VERSUS SMOOTH-MUSCLE TISSUES
    European journal of pharmacology
    
    G.R. Seabrook et al., "DIFFERENCES IN THE EFFECTS OF TACHYKININ NK(1) RECEPTOR ANTAGONISTS -NEURONAL VERSUS SMOOTH-MUSCLE TISSUES", European journal of pharmacology, 250(1), 1993, pp. 125-131
40. RUPNIAK NMJ; BOYCE S; WILLIAMS AR; COOK G; LONGMORE J; SEABROOK GR; CAESER M; IVERSEN SD; HILL RG
    ANTINOCICEPTIVE ACTIVITY OF NK(1) RECEPTOR ANTAGONISTS - NONSPECIFIC EFFECTS OF RACEMIC RP67580
    British Journal of Pharmacology
    
    N.M.J. Rupniak et al., "ANTINOCICEPTIVE ACTIVITY OF NK(1) RECEPTOR ANTAGONISTS - NONSPECIFIC EFFECTS OF RACEMIC RP67580", British Journal of Pharmacology, 110(4), 1993, pp. 1607-1613